Alert on Fake Mencevax Meningitis Vaccines Circulating in Niger Republic

0

The National Agency for Food and Drug Administration and Control (NAFDAC) alerts the public, especially the health care providers on the circulation of fake MencevaxTM ACWY and MencevaxTM ACW vaccines circulating in the Niger Republic. The Health Authorities of the Republic of Niger issued an alert on the fake vaccines discovered during routine inspections of the pharmacies in Niamey, the Niger Republic on 14th March 2019.

The Lot number of the fake MencevaxTM ACW vaccine is AMEN A020 AA while the Lot number of the fake MencevaxTM ACWY is AMEH A020 AA.

The fake MencevaxTM ACWY vaccine has a manufacturing date of December 2016 and an expiring date of November 2021.

Read:  Medview Boosts International Operations With B777-200ER

Genuine MencevaxTM ACW and MencevaxTM ACWY vaccines are used to control the outbreak of meningococcal infection.

The genuine vaccines were registered by NAFDAC in favour of Glaxo SmithKline Beecham (GSK). Pfizer acquired the vaccines from GSK in 2015.

Pfizer Specialties Limited, 7th Floor, Heritage Place, 21 Lugard Avenue, Ikoyi Lagos discontinued commercialization of Mencevax Vaccines in Nigeria in June 2018. As a result of the discontinuation of commercialization of the vaccines, Pfizer specialities Limited no longer import the vaccines into Nigeria.

NAFDAC implores all importers, wholesalers, and retailers not to illegally import, distribute and sell the fake Mencevax vaccines.

Read:  NAFDAC bans use of Methyl Bromide for pest control in crops

Surveillance has been strengthened by NAFDAC at all ports of entry to prevent importation of the fake vaccines from the Niger Republic. The agency has also heightened surveillance to prevent distribution and sales of the fake vaccines.

Health care providers and other members of the public are advised to be vigilant and contact the nearest NAFDAC office with any information on the fake vaccines.

Anybody in possession of the fake vaccines should submit it to the nearest NAFDAC office.

Consumers are advised to report adverse events related to the use of vaccines to the nearest NAFDAC office, NAFDAC PRASCOR ( 20543 TOLL-FREE for all Network ) or via pharmacovigilance@nafdac.gov.ng.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.